Fat Tissue and Liver Fat in Type 1 Diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how fat tissue works differently in people with type 1 diabetes who have belly fat, and how that might lead to fat buildup in the liver. It compares these people to those without diabetes, matched by age, waist size, and menopausal status, to find new ways to prevent liver problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes (T1D) and are on an insulin pump with continuous glucose monitoring.
- You have extra belly fat (abdominal obesity) based on your waist size.
- Your blood sugar is well-controlled (HbA1c under 6.0% if you don't have diabetes, or you spend at least 70% of time in target range if you have T1D).
- You are not pregnant or planning pregnancy in the next 6 months.
- You can safely have an MRI (no metal implants or devices inside your body).
- You don't smoke more than 1 cigarette per day or have more than 2 alcoholic drinks daily.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.
This study follows people with type 2 diabetes and a common liver condition called MASLD to see how their heart health changes over time. It aims to find better ways to prevent heart disease in people with both conditions.
This study looks at how fat in the muscles may affect liver disease in people with fatty liver and related conditions like obesity or diabetes. It aims to better understand the connection between muscle fat and liver health.
This study looks at how common liver fat build-up is in people with type 1 diabetes. It aims to understand what factors might increase the risk of liver problems.
This trial looks at how common fatty liver disease is in people with type 1 diabetes. Doctors will check your liver with tests to learn more and find out if you might be at risk.
This study measures how “blood fats” move in the body after fasting and controlled eating, comparing people with type 1 diabetes to those without diabetes. It may help researchers understand diabetes-related differences in lipid (fat) handling and improve future treatments.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.